|
US2913454A
(en)
*
|
1956-11-23 |
1959-11-17 |
Schenley Ind Inc |
Certain cycloalkanotriazoles, process and intermediates
|
|
US3723442A
(en)
*
|
1970-12-31 |
1973-03-27 |
Yoshitomi Pharmaceutical |
3-oxo-1-oxa-4,8-diazaspiro(4.5)decanes
|
|
US3784551A
(en)
*
|
1971-07-08 |
1974-01-08 |
Yoshitomi Pharmaceutical |
2-oxo-1,4-dioxa-8-azaspiro (4.5) decanes and related compounds
|
|
US4350696A
(en)
*
|
1980-03-08 |
1982-09-21 |
Pfizer Inc. |
Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
|
|
AU557300B2
(en)
*
|
1982-03-16 |
1986-12-18 |
Farmitalia Carlo Erba S.P.A. |
Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation
|
|
DE3445377A1
(de)
*
|
1983-12-23 |
1985-07-04 |
Sandoz-Patent-GmbH, 7850 Lörrach |
Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen
|
|
FI864875A0
(fi)
*
|
1986-11-28 |
1986-11-28 |
Orion Yhtymae Oy |
Nya farmakologiskt aktiva foereningar, dessa innehaollande kompositioner samt foerfarande och mellanprodukter foer anvaendning vid framstaellning av dessa.
|
|
US5283352A
(en)
*
|
1986-11-28 |
1994-02-01 |
Orion-Yhtyma Oy |
Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
|
|
YU213587A
(en)
*
|
1986-11-28 |
1989-06-30 |
Orion Yhtymae Oy |
Process for obtaining new pharmacologic active cateholic derivatives
|
|
US5750532A
(en)
*
|
1986-12-10 |
1998-05-12 |
Schering Corporation |
Pharmaceutically active compounds
|
|
US5272167A
(en)
*
|
1986-12-10 |
1993-12-21 |
Schering Corporation |
Pharmaceutically active compounds
|
|
US4851423A
(en)
*
|
1986-12-10 |
1989-07-25 |
Schering Corporation |
Pharmaceutically active compounds
|
|
US5225402A
(en)
*
|
1989-02-10 |
1993-07-06 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
|
GB8904174D0
(en)
*
|
1989-02-23 |
1989-04-05 |
British Bio Technology |
Compounds
|
|
US5169850A
(en)
*
|
1990-01-22 |
1992-12-08 |
American Cyanamid Company |
N-(dialkylamino)methylene)-substituted pyrazolo(1,5-a)-pyrimidine-3-carboxamides and N-(dialkylamino)methylene-substituted-4,5-dihydropyrazolo-(1,5-a)-pyrimidine-3-carboxamides
|
|
US5290803A
(en)
*
|
1990-02-12 |
1994-03-01 |
The Center Of Innovative Technology |
Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
|
|
US5382680A
(en)
*
|
1990-12-07 |
1995-01-17 |
The Center For Innovative Technology |
Allosteric hemoglobin modifier compounds
|
|
US5648375A
(en)
*
|
1990-02-12 |
1997-07-15 |
Virginia Commonwealth University |
Use of hydrophobic compounds and anesthetics in combination with allosteric hemoglobin modifiers
|
|
US5049695A
(en)
*
|
1990-02-12 |
1991-09-17 |
Center For Innovative Technology |
Allosteric hemoglobin modifiers
|
|
US5591892A
(en)
*
|
1990-02-12 |
1997-01-07 |
Center For Innovative Technology |
Allosteric modifiers of hemoglobin
|
|
US5432191A
(en)
*
|
1990-02-12 |
1995-07-11 |
The Center For Innovative Technology |
Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
|
|
US5122539A
(en)
*
|
1990-02-12 |
1992-06-16 |
Center For Innovative Technology |
Allosteric hemoglobin modifiers useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
|
|
US5731454A
(en)
*
|
1990-02-12 |
1998-03-24 |
Virginia Commonwealth University |
Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
|
|
US5677330A
(en)
*
|
1990-02-12 |
1997-10-14 |
The Center For Innovative Technology |
Medical uses of allosteric hemoglobin modifier compounds in patient care
|
|
US5705521A
(en)
*
|
1990-02-12 |
1998-01-06 |
The Center For Innovative Technology |
Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors
|
|
US5872282A
(en)
*
|
1990-12-07 |
1999-02-16 |
Virginia Commonwealth University |
Allosteric modifiers of hemoglobin
|
|
FR2677984B1
(fr)
*
|
1991-06-21 |
1994-02-25 |
Elf Sanofi |
Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
|
US5260325A
(en)
*
|
1991-08-19 |
1993-11-09 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking tertiary amides
|
|
US5258407A
(en)
*
|
1991-12-31 |
1993-11-02 |
Sterling Winthrop Inc. |
3,4-disubstituted phenols-immunomodulating agents
|
|
US5356904A
(en)
*
|
1992-10-07 |
1994-10-18 |
Merck & Co., Inc. |
Carbostyril oxytocin receptor antagonists
|
|
RU2126802C1
(ru)
*
|
1992-12-04 |
1999-02-27 |
Жансен Фармасетика Н.В. |
Производные триазолбензазепина, способы их получения, промежуточные соединения для их получения, фармацевтическая антигистаминная композиция и способ ее получения
|
|
US5571813A
(en)
*
|
1993-06-10 |
1996-11-05 |
Beiersdorf-Lilly Gmbh |
Fused pyrimidine compounds and their use as pharmaceuticals
|
|
US5395846A
(en)
*
|
1993-06-25 |
1995-03-07 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Amino Bi- and tri-carbocyclic aklane bis-aryl squalene synthase inhibitors
|
|
FR2708608B1
(fr)
*
|
1993-07-30 |
1995-10-27 |
Sanofi Sa |
Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
|
|
EP0720601B1
(en)
*
|
1993-08-10 |
2000-10-25 |
James Black Foundation Limited |
Gastrin and cck receptor ligands
|
|
US5426105A
(en)
*
|
1993-09-24 |
1995-06-20 |
G.D. Searle & Co. |
Conformationally restricted angiotensin II antagonists
|
|
US5674879A
(en)
*
|
1993-09-24 |
1997-10-07 |
G.D. Searle & Co. |
Compositions including and methods of using conformationally restricted angiotensin II antagonist
|
|
TW279860B
(OSRAM)
*
|
1993-11-12 |
1996-07-01 |
Ciba Geigy Ag |
|
|
GB9409150D0
(en)
*
|
1994-05-09 |
1994-06-29 |
Black James Foundation |
Cck and gastrin receptor ligands
|
|
US5795907A
(en)
*
|
1994-05-27 |
1998-08-18 |
James Black Foundation Limited |
Gastin and CCK receptor ligands
|
|
EP0763026B1
(en)
*
|
1994-05-27 |
2003-03-26 |
James Black Foundation Limited |
Gastrin and cck antagonists
|
|
SK27198A3
(en)
*
|
1995-08-30 |
1998-09-09 |
Bayer Ag |
Acylaminosalicylic acid amides and their uses as pesticides
|
|
FR2741878B1
(fr)
*
|
1995-12-01 |
1998-01-09 |
Cird Galderma |
Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations
|
|
TW359669B
(en)
*
|
1995-12-15 |
1999-06-01 |
Otsuka Pharma Co Ltd |
Benzazepine derivatives
|
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
|
JP2001526648A
(ja)
*
|
1997-04-22 |
2001-12-18 |
コセンシス・インコーポレイテッド |
炭素環及びヘテロ環で置換されたセミカルバゾン及びチオセミカルバゾン、及びその使用
|
|
US6506783B1
(en)
*
|
1997-05-16 |
2003-01-14 |
The Procter & Gamble Company |
Cancer treatments and pharmaceutical compositions therefor
|
|
US6521641B1
(en)
*
|
1998-10-08 |
2003-02-18 |
Allergan, Inc. |
Male anti-fertility agents
|
|
US6541477B2
(en)
*
|
1999-08-27 |
2003-04-01 |
Scios, Inc. |
Inhibitors of p38-a kinase
|
|
US6458849B1
(en)
*
|
1999-09-23 |
2002-10-01 |
G.D. Searle & Co. |
use of substituted N,N-disubstituted mercapto amino compounds for inhibiting cholesteryl ester transfer protein activity
|
|
SE0001899D0
(sv)
*
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
US6482829B2
(en)
*
|
2000-06-08 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor
|
|
US7129242B2
(en)
*
|
2000-12-06 |
2006-10-31 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
|
|
CA2480856A1
(en)
*
|
2002-04-05 |
2003-10-23 |
Merck & Co., Inc. |
Substituted aryl amides
|
|
BR0313041A
(pt)
*
|
2002-07-29 |
2005-06-21 |
Hoffmann La Roche |
Compostos; composições farmacêuticas; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação dos receptores de cb1; e uso de compostos
|
|
US7186735B2
(en)
*
|
2002-08-07 |
2007-03-06 |
Sanofi-Aventis Deutschland Gmbh |
Acylated arylcycloalkylamines and their use as pharmaceuticals
|
|
CA2504735C
(en)
*
|
2002-11-07 |
2009-06-23 |
Merck & Co., Inc. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
WO2004056744A1
(en)
*
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
|
AU2004215481B2
(en)
*
|
2003-02-28 |
2010-11-11 |
Teijin Pharma Limited |
Pyrazolo(1,5-A)pyrimidine derivatives
|
|
US7320989B2
(en)
*
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
WO2004078114A2
(en)
*
|
2003-02-28 |
2004-09-16 |
Encysive Pharmaceuticals Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists.
|
|
US20060094699A1
(en)
*
|
2003-04-11 |
2006-05-04 |
Kampen Gita Camilla T |
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
|
|
US20070270408A1
(en)
*
|
2003-04-11 |
2007-11-22 |
Novo Nordisk A/S |
Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines
|
|
EP1615698B1
(en)
*
|
2003-04-11 |
2010-09-29 |
High Point Pharmaceuticals, LLC |
New amide derivatives and pharmaceutical use thereof
|
|
US7700583B2
(en)
*
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
|
ES2338656T3
(es)
*
|
2003-04-11 |
2010-05-11 |
High Point Pharmaceuticals, Llc |
Uso farmaceutico de 1,2,4-triazoles fusionados.
|
|
US7501405B2
(en)
*
|
2003-04-11 |
2009-03-10 |
High Point Pharmaceuticals, Llc |
Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
|
|
WO2005007621A2
(en)
*
|
2003-05-30 |
2005-01-27 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
|
EP1670460B1
(en)
*
|
2003-10-10 |
2014-11-26 |
Bristol-Myers Squibb Company |
Pyrazole derivatives as cannabinoid receptor modulators
|
|
US20050261302A1
(en)
*
|
2004-04-29 |
2005-11-24 |
Hoff Ethan D |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
|
|
US20060009918A1
(en)
*
|
2004-07-08 |
2006-01-12 |
Sanku Mallik |
Methods and materials for enhancing the effects of protein modulators
|
|
WO2006040329A1
(en)
*
|
2004-10-12 |
2006-04-20 |
Novo Nordisk A/S |
1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds
|
|
US7217838B2
(en)
*
|
2005-01-05 |
2007-05-15 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
EA200801492A1
(ru)
*
|
2005-11-01 |
2008-10-30 |
Транстек Фарма |
Фармацевтическое применение замещенных амидов
|
|
EA200801243A1
(ru)
*
|
2005-11-01 |
2008-10-30 |
Транстек Фарма |
Фармацевтическое применение замещенных амидов
|
|
CA2646588A1
(en)
*
|
2006-03-21 |
2007-09-27 |
High Point Pharmaceuticals, Llc |
Adamantane derivatives for the treatment of the metabolic syndrome
|
|
US8053447B2
(en)
*
|
2006-04-07 |
2011-11-08 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
|
JP2010519239A
(ja)
*
|
2007-02-23 |
2010-06-03 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
１１−ベータ−ヒドロキシステロイドデヒドロゲナーゼの阻害因子としてのｎ−アドマンチルベンザミド
|
|
EP2125704A1
(en)
*
|
2007-02-23 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
ZA200904916B
(en)
*
|
2007-02-23 |
2010-09-29 |
High Point Pharmaceuticals Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
AU2007349112A1
(en)
*
|
2007-03-09 |
2008-09-18 |
High Point Pharmaceuticals, Llc |
Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
|
|
JP2010522766A
(ja)
*
|
2007-03-28 |
2010-07-08 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
１１ベータ−ｈｓｄ１活性化合物
|
|
WO2008134221A1
(en)
*
|
2007-04-24 |
2008-11-06 |
High Point Pharmaceuticals, Llc |
Pharmaceutical use of substituted amides
|
|
EP2362730A4
(en)
*
|
2008-11-21 |
2012-08-29 |
High Point Pharmaceuticals Llc |
Adamantyl BENZAMIDE CONNECTIONS
|